38 N9831 PPTs View free & download

B-31/N9831 First Interim Joint Analysis PowerPoint PPT Presentation

B-31/N9831 First Interim Joint Analysis - B-31/N9831 First Interim Joint Analysis NSABP Meeting Baltimore MD 17 September 2005 Edward H. Romond, M.D. Joint Analysis Flow Diagram Trial Number Registered1 ...

B-31/N9831 First Interim Joint Analysis NSABP Meeting Baltimore MD 17 September 2005 Edward H. Romond, M.D. Joint Analysis Flow Diagram Trial Number Registered1 ...

| PowerPoint PPT presentation | free to download

Trastuzumab plus Adjuvant Chemotherapy for HER2-Positive Breast Cancer: Final Planned Joint Analysis of Overall Survival from NSABP B-31 and NCCTG N9831 - Trastuzumab plus Adjuvant Chemotherapy for HER2-Positive Breast Cancer: Final Planned Joint Analysis of Overall Survival from NSABP B-31 and NCCTG N9831

Trastuzumab plus Adjuvant Chemotherapy for HER2-Positive Breast Cancer: Final Planned Joint Analysis of Overall Survival from NSABP B-31 and NCCTG N9831

| PowerPoint PPT presentation | free to download

Round-Robin Review of HER2 Testing in the Context of Adjuvant Therapy for Breast Cancer (NCCTG N9831/BCIRG006/BCIRG005)1 Concordance of HER2 Central Assessment by Two International Central Laboratories: A Ring Study within the Framework of the - ... be confirmed in the other central lab Central Laboratory HER2 % local false-positive ER % discordant IEO 14.5% of 8,037 12.1% of 9,021 Mayo Clinic 5.8% of ...

... be confirmed in the other central lab Central Laboratory HER2 % local false-positive ER % discordant IEO 14.5% of 8,037 12.1% of 9,021 Mayo Clinic 5.8% of ...

| PowerPoint PPT presentation | free to download

Phase III Trial of Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Paclitaxel With or Without Trastuzumab as Adjuvant Treatment for Women With HER-2 Overexpressing Node-Positive Breast Cancer - Phase III Trial of Doxorubicin and Cyclophosphamide (AC) ... Edith A. Perez, PI. N9831: Intergroup Trial for. Node , HER2 Breast Cancer. Paclitaxel qw x 12 ...

Phase III Trial of Doxorubicin and Cyclophosphamide (AC) ... Edith A. Perez, PI. N9831: Intergroup Trial for. Node , HER2 Breast Cancer. Paclitaxel qw x 12 ...

| PowerPoint PPT presentation | free to download

Targeted%20Adjuvant%20Systemic%20Therapy%20of%20Breast%20Cancer%20Current%20 PowerPoint PPT Presentation

Targeted%20Adjuvant%20Systemic%20Therapy%20of%20Breast%20Cancer%20Current%20 - Targeted Adjuvant Systemic Therapy of Breast Cancer. Current & Future Role of Trastuzumab ... or High Risk Node (-) Breast Cancer. NCCTG N9831. May 2005 Update ...

Targeted Adjuvant Systemic Therapy of Breast Cancer. Current & Future Role of Trastuzumab ... or High Risk Node (-) Breast Cancer. NCCTG N9831. May 2005 Update ...

| PowerPoint PPT presentation | free to download

ONCOFARMACOGEN PowerPoint PPT Presentation

ONCOFARMACOGEN - Title: Presentaci n de PowerPoint Author: Packard Bell NEC, Inc. Last modified by: Administrador Created Date: 3/19/2001 8:15:16 PM Document presentation format

Title: Presentaci n de PowerPoint Author: Packard Bell NEC, Inc. Last modified by: Administrador Created Date: 3/19/2001 8:15:16 PM Document presentation format

| PowerPoint PPT presentation | free to download

Targeted therapy in Early Breast Cancer PowerPoint PPT Presentation

Targeted therapy in Early Breast Cancer - The incidence of cardiac events reach a plateau at around 1 year ... survival, time to recurrence, and time to ... NOAH study: neoadjuvant Herceptin for LABC ...

The incidence of cardiac events reach a plateau at around 1 year ... survival, time to recurrence, and time to ... NOAH study: neoadjuvant Herceptin for LABC ...

| PowerPoint PPT presentation | free to view

Titre - Title: Titre Author: Indiana Jones Created Date: 7/5/2003 6:34:05 AM Document presentation format: Affichage l' cran Company: Rolling Stones Company

Title: Titre Author: Indiana Jones Created Date: 7/5/2003 6:34:05 AM Document presentation format: Affichage l' cran Company: Rolling Stones Company

| PowerPoint PPT presentation | free to download

Targeted Adjuvant Systemic Therapy of Breast Cancer Current - Targeted Adjuvant Systemic Therapy of Breast Cancer Current

Targeted Adjuvant Systemic Therapy of Breast Cancer Current

| PowerPoint PPT presentation | free to view

Neil Love, MD PowerPoint PPT Presentation

Neil Love, MD - Current Patterns of Care: Case C a 55 yo with a 2.4-cm, Grade II, ER/PR ... Oak Lawn, Illinois ... 12:05 PM Dr Love: Current patterns of care in the community ...

Current Patterns of Care: Case C a 55 yo with a 2.4-cm, Grade II, ER/PR ... Oak Lawn, Illinois ... 12:05 PM Dr Love: Current patterns of care in the community ...

| PowerPoint PPT presentation | free to download

Treatment Options for Women with HER2 Positive Breast Cancer PowerPoint PPT Presentation

Treatment Options for Women with HER2 Positive Breast Cancer - pathophysiology of HER-2 family of proteins. diagnostic testing ... Paclitaxel for patients who had received adjuvant anthracycline. R. A. N. D. O. M. I. Z. E ...

pathophysiology of HER-2 family of proteins. diagnostic testing ... Paclitaxel for patients who had received adjuvant anthracycline. R. A. N. D. O. M. I. Z. E ...

| PowerPoint PPT presentation | free to view

Kathy D. Miller, MD PowerPoint PPT Presentation

Kathy D. Miller, MD - Discussion Topics HER2 positive disease Growing number of options Angiogenesis Bevacizumab questions answered and rephrased Small molecule success and ...

Discussion Topics HER2 positive disease Growing number of options Angiogenesis Bevacizumab questions answered and rephrased Small molecule success and ...

| PowerPoint PPT presentation | free to download

Targeted adjuvant systemic therapy: Current status and future directions of Trastuzumab PowerPoint PPT Presentation

Targeted adjuvant systemic therapy: Current status and future directions of Trastuzumab - ... it expects an ultimate enrollment of 8,000 patients Co-amplification of c-myc and HER2: benefit of trastuzumab Co-amplification of c-myc and HER2: ...

... it expects an ultimate enrollment of 8,000 patients Co-amplification of c-myc and HER2: benefit of trastuzumab Co-amplification of c-myc and HER2: ...

| PowerPoint PPT presentation | free to view

Presentazione di PowerPoint PowerPoint PPT Presentation

Presentazione di PowerPoint - Title: Presentazione di PowerPoint Author: Oncologia Last modified by: Oncologia Created Date: 10/21/2006 12:05:09 PM Document presentation format

Title: Presentazione di PowerPoint Author: Oncologia Last modified by: Oncologia Created Date: 10/21/2006 12:05:09 PM Document presentation format

| PowerPoint PPT presentation | free to view

New Technologies and Challenges Targeted Therapies in Cancer PowerPoint PPT Presentation

New Technologies and Challenges Targeted Therapies in Cancer - ... Extravasation Myelosuppression Cardiotoxicity Second Cancer Emesis Mucositis ... Slide 6 Potential mechanisms of Glivec ...

... Extravasation Myelosuppression Cardiotoxicity Second Cancer Emesis Mucositis ... Slide 6 Potential mechanisms of Glivec ...

| PowerPoint PPT presentation | free to download

HER2NEU and breast cancer. PowerPoint PPT Presentation

HER2NEU and breast cancer. - HER2-neu (human epidermal growth factor receptor 2) ... Ventana PATHWAYTM HER-2: automated staining system ~2300000 ~500000 ~100000 ...

HER2-neu (human epidermal growth factor receptor 2) ... Ventana PATHWAYTM HER-2: automated staining system ~2300000 ~500000 ~100000 ...

| PowerPoint PPT presentation | free to view

Targeted treatment with antibodies, small molecules and other approaches adjuvant treatment with tra PowerPoint PPT Presentation

Targeted treatment with antibodies, small molecules and other approaches adjuvant treatment with tra - adjuvant treatment with trastuzumab. AGO Organkommission 'Mamma' as of July 19th, 2005 ... Adjuvant treatment with trastuzumab in primary breast cancer patients ...

adjuvant treatment with trastuzumab. AGO Organkommission 'Mamma' as of July 19th, 2005 ... Adjuvant treatment with trastuzumab in primary breast cancer patients ...

| PowerPoint PPT presentation | free to view

DEPARTMENT OF ONCOLOGY AND HEMATOLOGY PowerPoint PPT Presentation

DEPARTMENT OF ONCOLOGY AND HEMATOLOGY - DEPARTMENT OF ONCOLOGY AND HEMATOLOGY UNIVERSITY OF MODENA AND REGGIO EMILIA MODENA, ITALY I fattori prognostici del tumore della mammella: possibile un approccio ...

DEPARTMENT OF ONCOLOGY AND HEMATOLOGY UNIVERSITY OF MODENA AND REGGIO EMILIA MODENA, ITALY I fattori prognostici del tumore della mammella: possibile un approccio ...

| PowerPoint PPT presentation | free to view

Premenopausal Early Breast Cancer: Medical Management PowerPoint PPT Presentation

Premenopausal Early Breast Cancer: Medical Management - form of adjuvant systemic therapy ... Adjuvant Chemotherapy. Adjuvantonline describes 1st, 2nd and 3rd generation regimens ... Current Adjuvant Trials for HER2 ve pts ...

form of adjuvant systemic therapy ... Adjuvant Chemotherapy. Adjuvantonline describes 1st, 2nd and 3rd generation regimens ... Current Adjuvant Trials for HER2 ve pts ...

| PowerPoint PPT presentation | free to view

POST ASCO2007 EMLO ADJUVNS PowerPoint PPT Presentation

POST ASCO2007 EMLO ADJUVNS - A meta-analysis of taxanes in adjuvant chemotherapy (ACT) of early breast cancer ... Survival with adjuvant surgical oophorectomy and tamoxifen in premenopausal ...

A meta-analysis of taxanes in adjuvant chemotherapy (ACT) of early breast cancer ... Survival with adjuvant surgical oophorectomy and tamoxifen in premenopausal ...

| PowerPoint PPT presentation | free to view

Medical Management of Breast Cancer in Premenopausal Women PowerPoint PPT Presentation

Medical Management of Breast Cancer in Premenopausal Women - Head of Breast Medical Oncology. Peter MacCallum Cancer Centre ... Pathology Information Required for. Optimal Systemic Therapy Decisions ...

Head of Breast Medical Oncology. Peter MacCallum Cancer Centre ... Pathology Information Required for. Optimal Systemic Therapy Decisions ...

| PowerPoint PPT presentation | free to view

-

| PowerPoint PPT presentation | free to download

CONGRESO CHILENO DE CANCEROLOGIA PowerPoint PPT Presentation

CONGRESO CHILENO DE CANCEROLOGIA - CONGRESO CHILENO DE CANCEROLOGIA TERAPIAS BIOLOGICAS DIRIGIDAS EN CANCER DE MAMA Dr. Jorge Luis Soriano Garc a Ph.D. Jefe Servicio de Oncolog a Cl nica

CONGRESO CHILENO DE CANCEROLOGIA TERAPIAS BIOLOGICAS DIRIGIDAS EN CANCER DE MAMA Dr. Jorge Luis Soriano Garc a Ph.D. Jefe Servicio de Oncolog a Cl nica

| PowerPoint PPT presentation | free to view

Aucun titre de diapositive PowerPoint PPT Presentation

Aucun titre de diapositive - Les th rapeutiques cibl es dans le cancer du sein Mythes ou r alit s ? Dr. Thomas Bachelot Centre L on B rard, Lyon

Les th rapeutiques cibl es dans le cancer du sein Mythes ou r alit s ? Dr. Thomas Bachelot Centre L on B rard, Lyon

| PowerPoint PPT presentation | free to download

Management of Her 2 Positive Breast Cancer in the Adjuvant Setting PowerPoint PPT Presentation

Management of Her 2 Positive Breast Cancer in the Adjuvant Setting - Needle biopsy showed invasive ductal carcinoma, grade III/III with ductal ... (Central FISH) N or high. risk N- 4 x AC. 60/600 mg/m2. 4 x Docetaxel. 100 mg/m2 ...

Needle biopsy showed invasive ductal carcinoma, grade III/III with ductal ... (Central FISH) N or high. risk N- 4 x AC. 60/600 mg/m2. 4 x Docetaxel. 100 mg/m2 ...

| PowerPoint PPT presentation | free to view

Cardiac Toxicity in Oncology: Why and When PowerPoint PPT Presentation

Cardiac Toxicity in Oncology: Why and When - To provide information on the cardiac risks of chemotherapy and the various ... Long-tern cardiac toxicity for survivors of childhood leukemia ...

To provide information on the cardiac risks of chemotherapy and the various ... Long-tern cardiac toxicity for survivors of childhood leukemia ...

| PowerPoint PPT presentation | free to view

BREAST CANCER PowerPoint PPT Presentation

BREAST CANCER - Fine Needle Aspiration. Ultrasound Guided Core Biopsy. Excisional or Incisional Biopsy ... her-2neu (FISH) ER/PR - % Reduction Breast Cancer Mortality ...

Fine Needle Aspiration. Ultrasound Guided Core Biopsy. Excisional or Incisional Biopsy ... her-2neu (FISH) ER/PR - % Reduction Breast Cancer Mortality ...

| PowerPoint PPT presentation | free to view

Neoadjuvante systemische therapie Een goed begin''' PowerPoint PPT Presentation

Neoadjuvante systemische therapie Een goed begin''' - (Neo-)adjuvante systemische therapie. Een goed begin... Marijke Bontenbal ... RHEA. Relapse. Surgery. 2nd lines. NOAH. MDACC. GeparQuattro. Numerous Phase II studies ...

(Neo-)adjuvante systemische therapie. Een goed begin... Marijke Bontenbal ... RHEA. Relapse. Surgery. 2nd lines. NOAH. MDACC. GeparQuattro. Numerous Phase II studies ...

| PowerPoint PPT presentation | free to view

HER-2 targeting: dalla malattia avanzata alla fase pre-operatoria PowerPoint PPT Presentation

HER-2 targeting: dalla malattia avanzata alla fase pre-operatoria - HER-2 targeting: dalla malattia avanzata alla fase pre-operatoria Marco Venturini Roma, Febbraio 2005 Tailored Treatment of HER2+ MBC Trastuzumab + Taxanes ...

HER-2 targeting: dalla malattia avanzata alla fase pre-operatoria Marco Venturini Roma, Febbraio 2005 Tailored Treatment of HER2+ MBC Trastuzumab + Taxanes ...

| PowerPoint PPT presentation | free to view

Cancer and the Media - Cancer and the Media

Cancer and the Media

| PowerPoint PPT presentation | free to view

Diapositiva 1 PowerPoint PPT Presentation

Diapositiva 1 - CARCINOMA DELLA MAMMELLA The Aromatase Inhibitor Trials ATAC: Tamoxifen vs Anastrozole vs Combined therapy MA17 : Letrozole vs placebo after 5yr Tamoxifen IES ...

CARCINOMA DELLA MAMMELLA The Aromatase Inhibitor Trials ATAC: Tamoxifen vs Anastrozole vs Combined therapy MA17 : Letrozole vs placebo after 5yr Tamoxifen IES ...

| PowerPoint PPT presentation | free to download

Breast cancer treatment: The future is bright PowerPoint PPT Presentation

Breast cancer treatment: The future is bright - Calendar period ' ... Picture. Hormonal therapy. Hormonal therapy. Tamoxifen ... present a complex picture... Metastases. Inhibitors. EGFR. inhibitors ...

Calendar period ' ... Picture. Hormonal therapy. Hormonal therapy. Tamoxifen ... present a complex picture... Metastases. Inhibitors. EGFR. inhibitors ...

| PowerPoint PPT presentation | free to view

Radiothrapie des cancers du sein Sujets en discussion et controverses PowerPoint PPT Presentation

Radiothrapie des cancers du sein Sujets en discussion et controverses - Effets de la radioth rapie post-op ratoire sur les r cidives locor gionales et la survie ... Etabli de fa on empirique, compromis entre efficacit et risque de s quelles ...

Effets de la radioth rapie post-op ratoire sur les r cidives locor gionales et la survie ... Etabli de fa on empirique, compromis entre efficacit et risque de s quelles ...

| PowerPoint PPT presentation | free to view

THE CHOICES FOR BREAST CANCER TREATMENT - THE CHOICES FOR BREAST CANCER TREATMENT

THE CHOICES FOR BREAST CANCER TREATMENT

| PowerPoint PPT presentation | free to view

Essentials of ALTTO PowerPoint PPT Presentation

Essentials of ALTTO - Essentials of ALTTO Frances M Palmieri, RN, MSN, OCN, CCRP Nursing Liaison What is ALTTO Worldwide Collaboration Enrollment Update Rationale for Study Design ...

Essentials of ALTTO Frances M Palmieri, RN, MSN, OCN, CCRP Nursing Liaison What is ALTTO Worldwide Collaboration Enrollment Update Rationale for Study Design ...

| PowerPoint PPT presentation | free to download

PierFranco Conte PowerPoint PPT Presentation

PierFranco Conte - ... Treatment in Patients with FISH Positive Advanced or Metastatic Breast Cancer ... Advanced ErbB2 MBC. Prior treatment with trastuzumab allowed but not required ...

... Treatment in Patients with FISH Positive Advanced or Metastatic Breast Cancer ... Advanced ErbB2 MBC. Prior treatment with trastuzumab allowed but not required ...

| PowerPoint PPT presentation | free to view

???: ???? - Title: Slide 1 Author *** Last modified by: rmc Created Date: 4/28/2004 7:38:10 PM Document presentation format: Other titles

Title: Slide 1 Author *** Last modified by: rmc Created Date: 4/28/2004 7:38:10 PM Document presentation format: Other titles

| PowerPoint PPT presentation | free to view

Does Omitting IMC Irradiation Reduce Cardiac Exposure For All Breast Cancer Patients Treated With He PowerPoint PPT Presentation

Does Omitting IMC Irradiation Reduce Cardiac Exposure For All Breast Cancer Patients Treated With He - Does Omitting IMC Irradiation Reduce Cardiac Exposure For All Breast Cancer ... K. Feng, C.M.D., Andrzej Niemierko, Ph.D., Alphonse G. Taghian, M.D., Ph.D. ...

Does Omitting IMC Irradiation Reduce Cardiac Exposure For All Breast Cancer ... K. Feng, C.M.D., Andrzej Niemierko, Ph.D., Alphonse G. Taghian, M.D., Ph.D. ...

| PowerPoint PPT presentation | free to view

N9831 PowerPoint PPT Presentations